Development and validation of an individualized immune prognostic signature in colorectal cancer.

被引：0
|
作者：
Liu, Yang [1 ]
Zhang, Liwen [1 ]
You, Dong [1 ]
机构：
[1] Shanghai OrigiMed Co Ltd, Shanghai, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E15531 / E15531
页数：1
相关论文
共 50 条
  • [31] Development and Clinical Validation of a Novel 4-Gene Prognostic Signature Predicting Survival in Colorectal Cancer
    Yuan, Yihang
    Chen, Ji
    Wang, Jue
    Xu, Ming
    Zhang, Yunpeng
    Sun, Peng
    Liang, Leilei
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [32] Development and Validation of a Prognostic Nine Gene Expression Signature for Stage II/III Colorectal Cancer Patients
    Cheng, Liang
    Wang, Lisha
    Shen, Xiaohan
    Ren, Fei
    Sheng, Weiqi
    Zhou, Xiaoyan
    Du, Xiang
    MODERN PATHOLOGY, 2016, 29 : 165A - 165A
  • [33] Identification of a prognostic immune-related signature for small cell lung cancer.
    Wang, Jun
    Zhang, Bicheng
    Sun, Jianguo
    Liang, Jing
    Liu, Xiaolin
    Li, Yan
    Wang, Baocheng
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [34] Development of an Immune Infiltration-Related Eight-Gene Prognostic Signature in Colorectal Cancer Microenvironment
    Wu, Beilei
    Tao, Lijun
    Yang, Daqing
    Li, Wei
    Xu, Hongbo
    He, Qianggui
    BIOMED RESEARCH INTERNATIONAL, 2020, 2020
  • [35] Microbiome signature, global methylation and immune landscape in early onset colorectal cancer.
    Jin, Ning
    Mo, Xiaokui
    Hoyd, Rebecca
    Yilmaz, Ayse Selen
    Liu, YunZhou
    Singh, Malvenderjit Jagjit
    Muniak, Mitchell
    Hampel, Heather
    Spakowicz, Daniel
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [36] Development and Experimental Validation of a Novel Prognostic Signature for Gastric Cancer
    Liu, Chengcheng
    Huo, Yuying
    Zhang, Yansong
    Yin, Fumei
    Chen, Taoyu
    Wang, Zhenyi
    Gao, Juntao
    Jin, Peng
    Li, Xiangyu
    Shi, Minglei
    Zhang, Michael Q.
    CANCERS, 2023, 15 (05)
  • [37] Development and validation of a RNAseq signature for prognostic stratification in endometrial cancer
    Beinse, Guillaume
    Belda, Marie-Aude Le Frere
    Just, Pierre-Alexandre
    Bekmezian, Nahina
    Koual, Meriem
    Garinet, Simon
    Leroy, Karen
    Letourneur, Franck
    Lusson, Adele
    Mulot, Claire
    Le Corre, Delphine
    Metairie, Marie
    Delanoy, Nicolas
    Blons, Helene
    Gervais, Claire
    Durdux, Catherine
    Chapron, Charles
    Goldwasser, Francois
    Terris, Benoit
    Badoual, Cecile
    Taly, Valerie
    Laurent-Puig, Pierre
    Borghese, Bruno
    Bats, Anne-Sophie
    Alexandre, Jerome
    GYNECOLOGIC ONCOLOGY, 2022, 164 (03) : 596 - 606
  • [38] Development and validation of a metastasis-associated immune prognostic model for concurrent metastatic colorectal cancer
    Luo, Z.
    Zhao, H.
    Li, Z.
    Mao, R.
    Zhao, J.
    Ge, D.
    Zhang, F.
    Zhou, Y.
    Chen, X.
    Cai, J.
    Bi, X.
    ANNALS OF ONCOLOGY, 2019, 30 : 228 - 228
  • [39] Development and validation of an individualized angiogenesis and tumor-infiltrating lymphocytes prognostic signature in nasopharyngeal carcinoma
    Zhang, Ruyun
    Liao, Xiaofei
    Zhang, Bin
    Huang, Xiaohong
    Qin, Guanjie
    Kong, Xiangyun
    Xie, Yuan
    Mo, Yunyan
    Dai, Jinxuan
    Gan, Chunqiao
    Luo, Zan
    Lu, Jingyan
    Jiang, Wei
    PATHOLOGY RESEARCH AND PRACTICE, 2024, 253
  • [40] Development of an Immune-Related Prognostic Signature in Breast Cancer
    Xie, Peiling
    Ma, Yuying
    Yu, Shibo
    An, Rui
    He, Jianjun
    Zhang, Huimin
    FRONTIERS IN GENETICS, 2020, 10
12345